Music Intervention for Muscular Dystrophy
Trial Summary
Will I have to stop taking my current medications?
No, you will not have to stop taking your current medications. Participants are required to stay on stable medication from the day of screening to the end of the study.
Is music intervention safe for people with neuromuscular conditions?
How does the Dalcroze music education treatment differ from other treatments for muscular dystrophy?
Dalcroze music education is unique because it combines music and movement to improve physical, cognitive, and social abilities, which is different from traditional treatments that may focus solely on physical therapy or medication. This approach has shown benefits in improving balance, mobility, and social interaction, making it a novel option for enhancing quality of life in individuals with muscular dystrophy.678910
What is the purpose of this trial?
The goal of this interventional study is to demonstrate the feasibility and tolerability of Dalcroze music intervention for children with congenital DM1, while providing indications of its effectiveness in improving brain and heart symptoms of DM1. Additionally, information from the collection of biological samples and wearable devices (accelerometer, EEG headband and ECG chest strap) will be used to identify brain-heart biomarkers and outcome measures for use in future research and trials.Researchers will compare the results of physical and cognitive assessments for each participant to assessments from baseline after 10 weeks of weekly music sessions. Qualitative measures (questionnaires and focus groups) will inform the feasibility of this intervention for this population. The main questions this study aims to answer are:* Are weekly music education sessions feasible for children with DM1?* Are weekly music education sessions tolerable for children with DM1?Participants will:* Attend 45-minute-long music sessions once weekly for 10 weeks.* Attend two clinic visits for cognitive and physical assessments.* Provide blood, saliva, stool and urine samples.* Use wearable devices both at-home and during music sessions.* Parents/caregivers of participants will complete questionnaires and participate in three focus groups.
Eligibility Criteria
This trial is for children with congenital Myotonic Dystrophy Type 1 (DM1) who have brain and heart symptoms. They must be able to attend weekly music sessions for 10 weeks, provide biological samples, and use wearable devices for monitoring. Parents should also participate in questionnaires and focus groups.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend 45-minute-long music sessions once weekly for 10 weeks and provide biological samples
Follow-up
Participants are monitored for changes in physical and cognitive assessments, and qualitative feedback is collected
Extension
Participants may continue to use wearable devices for extended monitoring of brain-heart biomarkers
Treatment Details
Interventions
- Dalcroze music education
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hanns Lochmuller
Lead Sponsor
University of Ottawa
Collaborator